Recent Articles from GlobeNewswire

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Paysafe Limited (NYSE:PSFE) and StubHub Holdings, Inc. (NYSE:STUB). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Regencell Bioscience Holdings Limited (NASDAQ:RGC), Beyond Meat, Inc. (NASDAQ:BYND), Alvotech (NASDAQ:ALVO), and Camping World Holdings, Inc. (NYSE:CWH). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) --

Shareholders are encouraged to contact the firm now as there may be limited time to enforce your rights

Shareholders are encouraged to contact the firm as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

MINNEAPOLIS, Nov. 21, 2025 (GLOBE NEWSWIRE) -- We are incredibly honored to be recognized with 10 Clio Entertainment Awards.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) --

SAN DIEGO, Nov. 21, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) --

SAN CARLOS, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on November 20, 2025 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 164,900 shares of Iovance’s common stock to 11 new, non-executive employees.

SAN DIEGO, Nov. 21, 2025 (GLOBE NEWSWIRE) --

       BEIJING, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced that on November 18, 2025, it received a notice (the “Notice”) from The NASDAQ Stock Market LLC (“Nasdaq”) notifying that the Company is not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”), as the Company’s Class A ordinary shares had a closing bid price of $0.10 or less for the last ten consecutive trading days. The Notice indicated that, as a result, Nasdaq staff determined to delist the Company’s securities from The Nasdaq Capital Market (the “Delisting Determination”).

SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN) (“Opendoor” or the “Company”) today announced the distribution of warrants to purchase the Company’s common stock to its registered stockholders and certain convertible noteholders on Friday, November 21, 2025 (the “Distribution Date”), in accordance with the previously announced special dividend in the form of warrants. As previously announced, each stockholder of record as of 5:00 p.m. New York City time on November 18, 2025 (the “Record Date”) received three series of warrants—Series K, Series A, and Series Z—one (1) warrant of each series for every thirty (30) shares of the Company’s common stock held, rounded down to the nearest whole number.

Paris, France, Nov. 21, 2025 (GLOBE NEWSWIRE) -- LaFayette Acquisition Corp. (the “Company”) announced today that, commencing on or about Wednesday, November 26, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the ordinary shares and rights included in the units.

TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and other members of executive management will present at three upcoming investor conferences in December as follows:

SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Wednesday, December 3, 2025 at 12:55 p.m. ET.

NOVATO, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 18,180 restricted stock units of the company’s common stock to 12 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of November 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Figure Technology Solutions, Inc. (Nasdaq: FIGR), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of on-chain loan products and tokenized assets, today announced that it will participate in two upcoming investor conferences, both to be held on Wednesday, December 10, 2025.

ROCKVILLE, Md., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A. Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025, at 4:00 p.m. ET at the Lotte New York Palace in New York City.

CEDAR RAPIDS, Iowa, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Today, the board of directors of United Fire Group, Inc. (UFG) (Nasdaq: UFCS) declared a common stock quarterly cash dividend of $0.16 per share. This dividend will be payable December 19, 2025, to shareholders of record as of December 5, 2025.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Rent the Runway, Inc. (“Rent the Runway”) (Nasdaq: RENT) announced today that it expects to release its third quarter 2025 financial results for the quarter ended October 31, 2025 on Friday, December 12, 2025, before market open. Rent the Runway will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time that same day to discuss its results and to provide a business update.

Daix (France), New York City, (New York, United States), November 21, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), today reported its cash position as of September 30, 2025 and its revenues for the first nine months of 2025.

ABU DHABI, United Arab Emirates, Nov. 21, 2025 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIP Group” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced that it plans to report its unaudited financial results for the six months ended June 30, 2025, before the U.S. market opens on December 2, 2025.

Los Angeles, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Triller Group Inc. (“Triller”, “Triller Group” or “the Company”) today announced that on November 17, 2025, it received an additional delisting determination letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, since it failed to timely file its Form 10-Q for the period ended September 30, 2025, this serves as an additional basis for delisting.

PHILADELPHIA, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset tokenization technologies, announced today that, in connection with its previously announced distribution of Dream Bowl 2026 Meme Coins to eligible record equity holders of Datavault AI, Nasdaq has informed the Company that it is not expecting to quote an ex-dividend date for such distribution and therefore eligible record equity holders of Datavault AI must be holders as of the record date of November 25, 2025 in order to receive the distribution. 

The media is being deliberately misled on the meaning of the Supreme Court ruling

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Logitech International S.A. (“Logitech” or the “Company”) (NASDAQ: LOGI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Venu Holding Corporation (“Venu” or the “Company”) (NYSE: VENU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of StubHub Holdings, Inc. (“StubHub” or the “Company”) (NYSE: STUB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  SCHMID Group N.V. (“Schmid” or the “Company”) (NASDAQ: SHMD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  The Home Depot, Inc. (“Home Depot” or the “Company”) (NYSE: HD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Plug Power Inc. (“Plug” or the “Company”) (NASDAQ: PLUG).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Shareholders are encouraged to contact the firm to discuss their rights

SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- TrialWire™, the industry’s fastest, advanced AI-powered, algorithm-driven patient recruitment platform, today announced its RapidStart™ and RapidRescue™ solutions are ensuring that biotech-sponsored clinical trials continue enrolling patients without interruption across Thanksgiving and the upcoming holiday season—a period when traditional recruitment often stalls.

Nassau, The Bahamas, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Bahamas Ministry of Tourism, Investments & Aviation brought the vibrant spirit and warmth of the islands to the U.S. Northeast, hosting a pair of dynamic sales and marketing missions in New Jersey (November 18) and New York City (November 19). Led by the Honourable I. Chester Cooper, Deputy Prime Minister and Minister of Tourism, Investments & Aviation, alongside Director General Latia Duncombe, the delegation engaged travel trade, media, and industry partners through lively receptions, presentations, and cultural showcases celebrating the diversity and accessibility of The Bahamas.

Featuring artwork by Penelope Misa and inspired by the Blizzard athletes, the new collection redefines creativity and expression in skiing.

Tickets On Sale at 10:00 a.m. local time on Tuesday, Nov. 25, 2025

SEATTLE, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Snoqualmie Casino & Hotel, in partnership with Seattle’s 100.7 The Wolf, proudly announces the remarkable success of The Wolf’s Operation K9 Companion charity concert benefiting Northwest Battle Buddies, an organization dedicated to providing professionally trained service dogs to U.S. military Veterans living with PTSD.

PASCAGOULA, Miss., Nov. 21, 2025 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Ingalls Shipbuilding division successfully completed the final round of sea trials for Arleigh Burke-class guided missile destroyer Ted Stevens (DDG 128). The Ingalls Test and Trials team spent several days in port and at sea conducting a comprehensive series of acceptance test and evaluations, overseen by the Navy’s Board of Inspection and Survey (INSURV). These trials confirmed that the ship successfully demonstrated required mission capabilities, preparing it for delivery to the U.S. Navy in the coming weeks.

BAKERSFIELD, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Brain Injury Association of America (BIAA) honored Dr. Mark J. Ashley, Founder and Executive Chairman of the Board of Centre for Neuro Skills (CNS), as Luminary of the Year last Friday, November 14, 2025, at the National Press Club in Washington, D.C. The annual award celebrates individuals who have made outstanding contributions to the field of brain injury. The event shines a spotlight on powerful stories of resilience, courage and compassion from the brain injury community.

SLINGERLANDS, N.Y., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG) (the “Company” or “Plug”), a global leader in comprehensive hydrogen solutions for the hydrogen economy, will hold a Special Meeting of Stockholders (the “Special Meeting”) on January 15, 2026, at 10:00 a.m. Eastern Time. The meeting will be conducted in a virtual format only.

Transaction in Own Shares   

NEW YORK, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of New York (“FHLBNY”) announced today that Stephen S. Romaine has been elected by its Board of Directors (“Board”) to serve as Board vice chair for a two-year term that will commence on January 1, 2026. Mr. Romaine, who is chair and CEO of Tompkins Community Bank, has served on the FHLBNY’s Board as a Member Director since January 1, 2019. He currently serves as the chair of the Board’s Strategy & Business Committee and as a member of its Corporate Governance and External Affairs and Risk committees.

TORONTO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, announced today an update on its ongoing research study evaluating Bucillamine as a potential treatment for nerve agent exposure. The study is being conducted in collaboration with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency within the Canadian Department of National Defence that provides extensive expertise, infrastructure, and scientific capabilities to support the development of medical countermeasures. DRDC is evaluating pharmacological compounds, including Bucillamine, that may mitigate nerve agent–induced brain injury.

SLINGERLANDS, N.Y., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced the successful closing of the previously announced offering of $375 million aggregate principal amount of 6.75% convertible notes due 2033, including the full exercise of the initial purchasers’ option to purchase an additional $56.25 million aggregate principal amount of the notes, resulting in a total aggregate principal amount of $431.25 million. Plug received total net proceeds from the offering of approximately $399.4 million, after deducting the initial purchasers’ discount and estimated offering expenses.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna Medicare Advantage plans through CVS Health Corporation (“CVS”) for breach of contract and related violations of state laws.

Recognized for Completeness of Vision and Ability to Execute

NEWPORT NEWS, Va., Nov. 21, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Newport News Shipbuilding division has delivered Virginia-class fast-attack submarine Massachusetts (SSN 798) to the U.S. Navy.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Jayud Global Logistics Limited (“Jayud” or “the Company”) (NASDAQ: JYD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

MONACO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- A new and significant achievement for the Yacht Club de Monaco. The Yachting Masterclass course at YCM's La Belle Classe Academy has been officially accredited by the International Association of Maritime Institutions (IAMI), the global authority which sets and guarantees professional maritime and yachting training standards. The announcement was made by YCM General Secretary Bernard d’Alessandri at the diploma awards ceremony for the Yachting Masterclass’s fifth year-class. “This certification is proof that our programmes now meet the high standards expected by professionals in the sector. It is a unique, internationally focused programme that provides a 360o view of the yachting industry. My warmest congratulations go to our 19 graduates, not only students but also professionals moving onto new careers, who represent 13 nations. By joining the La Belle Classe Academy alumni, your sights are firmly set on excellence and being ambassadors for a yachting industry that I want to be sustainable”.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Primo Brands Corporation (“Primo” or “the Company”) (NYSE: PRMB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Freeport-McMoRan Inc. (“Freeport” or “the Company”) (NYSE: FCX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NASDAQ: FLY) for violations of the federal securities laws.

LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.